Skip to main content

Table 2 Toxicities according to CTCAE, version 4.0 (grade 3 or higher)

From: Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study

Characteristics

Total (n = 26)

No. of patients (%)

Hematotoxicity

 Neutropenia

14 (53.8)

 Febrile neutropenia

2 (7.7)

 Anemia

1 (3.8)

Nonhematotoxicity

 Infection

2 (7.7)

 Nausea

1 (3.8)

 Fatigue

1 (3.8)

 Diarrhea

2 (7.7)

 Spinal infarction

1 (3.8)

 Renal dysfunction

1 (3.8)

 Hypertension

1 (3.8)

 Perforation

2 (7.7)